Scribd Logo
Upload

Welcome to Scribd!

  • 128 views

    Surgical Site Infections

    Uploaded by

    Sheryl Durr

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    Surgical Site Infections

    Uploaded by

    Sheryl Durr
    128 views22 pages

    Original Title

    Surgical site infections.pptx

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    128 views22 pages

    Surgical Site Infections

    Uploaded by

    Sheryl Durr

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    of 22

    SURGICAL SITE

    INFECTIONS
    Presented by:
    Sheryl Durr, DNP, MSN, CRRN, CWCN, COCN
    Department of Wound Care Grady Heath
    System

    Surgical Site Infections (SSI)


    OBJECTIVES
    1.
    2.

    3.
    4.

    5.

    6.

    The practitioner will define and describe rationale for the prevention of
    wound infection in surgical patients.
    The practitioner will describe the roles of proteases within both acute
    and chronic wounds and how the manipulation of protease activity may
    aid in wound healing and decreasing surgical site infections.
    The practitioner will identify the four major phases and sequences of
    acute wound healing.
    The practitioner will become familiar with the advanced wound care
    products used to decreased bacterial proliferation in acute wounds
    (surgical, traumatic and chronic).
    The practitioner will consider the importance of cost-effectiveness in
    prevention of surgical site infections using advanced wound care
    products.
    The practitioner will describe evidence-based practices for prevention of
    SSI

    Surgical Site Infections (SSI)


    https://
    www.youtube.com/
    watch?v=XdKlmyfp
    5_w
    Human Skin

    Human Skin

    Surgical Site Infections

    And Post-Operative
    Outcomes

    SURGICAL SITE
    INFECTION
    Background/Epidemiology
    SSI infection generally occurs within 30 days
    following
    surgery
    Some procedures monitored up to 90 days for
    SSI
    2% -5% surgical patients acquire SSI (300500K per year)
    3% die (77% of deaths directly attributable to
    the SSI)
    Many result in long term disability
    SSI increases hospital length of stay 7-10 days
    Cost estimates vary, ~$30,000 per SSI
    Most estimates do not account for rehospitalization,
    outpatient treatment, post-discharge expenses,

    SURGICAL SITE INFECTION


    Pathogenesis of SSI
    Source of infecting
    pathogen
    Endogenous
    Patient Flora
    Skin
    GI tract
    Mucous membranes
    Seeding from preexisting
    sites of infection

    SURGICAL SITE INFECTION


    Pathogenesis of SSI
    Exogenous
    Surgical personnel flora
    Breaks in aseptic
    techniques
    Inadequate hand hygiene
    Contaminated garments
    Equipment, surgical tools,
    materials within operative
    field
    OR environment, including
    ventilation

    SURGICAL SITE INFECTION


    SSI Pathogens
    Staphylococcus aureus - 30.0%
    Coagulase-negative
    staphylococci - 13.7%
    Enterococcus spp - 11.2%
    Escherichia coli - 9.6%
    Pseudomonas aeruginosa - 5.6%
    Enterobacter spp - 4.2%
    Klebsiella pneumonia - 3.0%
    Candida spp - 2.0%
    Klebsiella oxytoca - 0.7%
    Acinetobacter baumannii - 0.6%

    SURGICAL SITE INFECTION


    CDC Prevention Strategies Core
    WOUND CARE
    Surgical Wound Dressing
    Protect primary closure incisions
    with sterile dressing for 24-48
    hours post-op
    Question..What is our current
    best practice for post-op
    dressings?
    What is our current post-op
    dressing change protocol?
    What are our evidence-based
    wound care products used (At
    Grady) in prevention of SSIs?

    Innovative Wound Care Products


    in Preventing Wound Infection
    Current State

    3M Tegaderm Absorbent Clear


    Acrylic Dressing

    Future State
    Using Improved
    Surgical
    Dressings

    Innovative Wound Care Products in Preventing Wound Infection


    Ovine-Based Collagen Matrix Dressing: Next-Generation
    Collagen Dressing for Wound Care
    Collagen ECM dressing to treat acute and chronic
    wounds from Day One.
    Contains 90% native, intact collagen and 10%
    extracellular matrix components
    Broad spectrum MMP reduction
    Advanced care accessible to all clinicians
    Cost efficiency through weekly applications
    A collagen ECM treatment option within your reach
    Can be used to treat chronic wounds from Day One
    No physician fixation required
    Accessible to all healthcare providers across the
    continuum of care
    Endoform dermal template dressings may be reapplied
    as infrequently as once per week, reducing cost and
    inconvenience compared to other collagen dressings
    that may need reapplication more than twice as often,
    per the instructions for use.
    http://www.hollisterwoundcare.com/products/endoform
    .aspx

    Innovative Wound Care Products in Preventing


    Wound Infection
    Ovine-Based Collagen Matrix Dressing: NextGeneration Collagen Dressing for Wound Care
    Significance: Broad-spectrum
    metalloproteinase (MMP)
    reduction along with inherent
    aspects of an extracellular
    matrix (ECM) dressing can
    bring about improved wound
    healing outcomes and
    shorter treatment duration.
    Initial reports of clinical
    effectiveness of a new ovinebased collagen extracellular
    matrix (CECM) dressing
    demonstrate benefits in
    chronic wound healing.

    Innovative Wound Care Products in


    Preventing Wound Infection
    Treated with
    When Managing Bioburden is a Priority.
    Antibacterial Protection
    Provides a protective antibacterial cover that inhibits the growth of
    microorganisms
    Physically binds harmful endotoxins1 which can aid in patient comfort
    Hydrofera Blue foam is effective against microorganisms
    commonly found in wounds including MRSA, VRE and Candida.
    Compatible for use with enzymatic debridement agents and growth
    factors
    Highly Absorptive
    Pulls bacteria-laden exudate up and away from the wound which may
    facilitate healing and aid in patient comfort
    Maintains similar or superior absorbency as compared to other highly
    absorptive dressings

    Indications for Use:

    pressure ulcers
    diabetic ulcers
    venous stasis ulcers
    arterial ulcers
    superficial burns
    donor sites
    post-surgical incisions
    trauma wounds
    abrasions
    lacerations

    Innovative Wound Care Products in Preventing


    Wound Infection
    Treated with Hydrofera Blue Ready

    May 31, 2016

    June 6, 2016

    Innovative Wound Care Products in Preventing


    Wound Infection
    Treated with Hydrofera Blue Ready

    June 10,
    2016

    June 13, 2016

    Innovative Wound Care Products in


    Preventing Wound Infection
    Treated with Hydrofera Blue Ready

    June 24, 2016

    July 11, 2016

    Innovative Wound Care Products in


    Preventing Wound Infection Medihoney

    Innovative Wound Care Products in Preventing


    Wound Infection Medihoney initially for
    Debridement and Now treated with Hydrofera Blue
    Irradiate
    d Skin
    after
    tumor
    resectio
    n

    May 20, 2016

    July 12, 2016

    Innovative Wound Care Products in


    Preventing Wound Infection and Dehiscence

    https://www.youtube.com/watch?
    v=T4MiTf-EM8w

    Thank you!
    Thats all Folks!!!!

    You might also like